Satellite images are highlighting China’s death surge, showing an uptick in the number of vehicles parked at funeral homes. A Pfizer-made COVID-19 drug is soon to be removed from China’s health insurance list. Beijing is complaining the drug is “too expensive,” while the drugmaker’s CEO disagrees. Bipartisan efforts are working to counter the Chinese communist…